September 23, 2004
Reaction
Although some HIV/AIDS experts were "skeptical" about NGEN's "unorthodox" methodology and said that a 17% prevalence rate was "too high," several also said that the government rate was "too low" and the country's "success story had been oversold," according to the Guardian (Guardian, 9/23). Dr. Elizabeth Namagala of the Ugandan Ministry of Health's AIDS Control Program said the NGEN research is "useful data" but "stressed" that the ministry's research was more scientific, BBC News reports (BBC News, 9/21). "We do not only count patients, we test patients," Namagala said, adding, "Not everyone who is sick actually has HIV, and not everyone who has HIV is sick" (Reuters, 9/21). The Ugandan government two months ago launched a nationwide survey of HIV prevalence and expects to publish its results next year, according to the Guardian. "I prefer to wait until then before commenting, but I would say that 17% sounds a little high," Ros Cooper, a health adviser at the U.K.'s Department for International Development in Uganda's capital Kampala, said. Beatrice Were, head of HIV/AIDS in Uganda for Action Aid, said that although NGEN's estimate was too high, governmental figures "overlooked" women who are unable to reach maternity clinics because of "poverty, remoteness or the war," according to the Guardian. "I would say the [prevalence] rate is between 10 and 12%" she said (Guardian, 9/23).
A kaisernetwork.org Newsmaker interview with Museveni, as well as video of his speech made in July at the XV International AIDS Conference in Bangkok, Thailand, is available online.
Back to other news for September 23, 2004
Search the Newsroom archive
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.